Roflumilast: Beneficios, Usos y Efectos Secundarios del Tratamiento ¿Qué es Roflumilast y para qué se utiliza? Roflumilast es un medicamento perteneciente a la clase de los inhibidores de la fosfodiesterasa-4 (PDE4). Se utiliza principalmente para tratar enfermedades respiratorias crónicas, especialmente la enfermedad... The post Roflumilast: Beneficios, Usos y Efectos Secundarios del Tratamiento first appeared on SoloSalud.net.

Roflumilast: Beneficios, Usos y Efectos Secundarios del Tratamiento #Roflumilast #SaludRespiratoria #Medicamentos

Arcutis Shows Positive Infant Roflumilast Data Arcutis (Nasdaq: ARQT) presented infant roflumilast data reported Mar 28, 2026; full dataset and regulatory intent will determine commercial and valuation impact.

Arcutis Shows Positive Infant Roflumilast Data: Arcutis (Nasdaq: ARQT) presented infant roflumilast data reported Mar 28, 2026; full dataset and regulatory intent will determine commercial and valuation… 👈 Read full analysis #Arcutis #Roflumilast #PediatricDermatology #InfantHealth #ClinicalTrials

Topical Roflumilast 0.3% Effective, Safe in Systematic Review of Psoriasis Data | HCPLive This systematic review and meta-analysis looked at research on the efficacy and safety of topical roflumilast 0.3% in patients with plaque psoriasis.

New findings suggest topical #roflumilast 0.3% significantly improves #psoriasis outcomes, including IGA and PASI scores, compared to placebo.

The systematic review and meta-analysis involved five RCTs with 1835 participants.

View more:

New from the FDA:

The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky

More details to come on contemporarypediatrics.com.

Arcutis Biotherapeutics has announced the commercial launch of #roflumilast 0.05% for the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.

Arcutis stated the topical formulation will be available in pharmacies this week.

www.contemporarypediatrics.com/view/lawrenc...

View a quick recap of data along with multiple comments from health care professionals on how #roflumilast can help children with the scalp and body #psoriasis. #Medsky #Pedsky

Read more: www.contemporarypediatrics.com/view/reactio...